Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryota Hashimoto

Showing results (381-390 of 467) with videos related to

Pageof 47
Sort By:
Sleep Medicine|December 7, 2021
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide studyRyuji Furihata, Rei Otsuki, Naomi Hasegawa, et al.
Schizophrenia Research|January 7, 2010
The chitinase 3-like 1 gene and schizophrenia: evidence from a multi-center case-control study and meta-analysisKazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, et al.
Neuron|June 23, 2017
High-Speed and Scalable Whole-Brain Imaging in Rodents and PrimatesKaoru Seiriki, Atsushi Kasai, Takeshi Hashimoto, et al.
Schizophrenia Bulletin|October 5, 2018
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic EffectMasashi Ikeda, Atsushi Takahashi, Yoichiro Kamatani, et al.
BMC Psychiatry|June 28, 2023
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment projectNaoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|November 2, 2023
Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control studyTzuyao Lo, Itaru Kushima, Hiroki Kimura, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 6, 2026
Optimizing multi-site schizophrenia differentiation: MRI harmonization with 20 controls per scanner in a study of 3560 subjects across 15 MRI scannersNaoki Hashimoto, Kiyotaka Nemoto, Masaki Fukunaga, et al.
Schizophrenia Research|February 25, 2009
Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter studyKazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, et al.
Biological Psychiatry|February 16, 2016
Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese PopulationTakeo Saito, Masashi Ikeda, Taisei Mushiroda, et al.
Neuropsychopharmacology Reports|July 1, 2020
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" projectKayo Ichihashi, Hikaru Hori, Naomi Hasegawa, et al.
Pageof 47

Showing results (381-390 of 467) with videos related to

Sort By:
Pageof 47
Sleep Medicine|December 7, 2021
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide studyRyuji Furihata, Rei Otsuki, Naomi Hasegawa, et al.
Schizophrenia Research|January 7, 2010
The chitinase 3-like 1 gene and schizophrenia: evidence from a multi-center case-control study and meta-analysisKazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, et al.
Neuron|June 23, 2017
High-Speed and Scalable Whole-Brain Imaging in Rodents and PrimatesKaoru Seiriki, Atsushi Kasai, Takeshi Hashimoto, et al.
Schizophrenia Bulletin|October 5, 2018
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic EffectMasashi Ikeda, Atsushi Takahashi, Yoichiro Kamatani, et al.
BMC Psychiatry|June 28, 2023
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment projectNaoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|November 2, 2023
Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control studyTzuyao Lo, Itaru Kushima, Hiroki Kimura, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 6, 2026
Optimizing multi-site schizophrenia differentiation: MRI harmonization with 20 controls per scanner in a study of 3560 subjects across 15 MRI scannersNaoki Hashimoto, Kiyotaka Nemoto, Masaki Fukunaga, et al.
Schizophrenia Research|February 25, 2009
Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter studyKazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, et al.
Biological Psychiatry|February 16, 2016
Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese PopulationTakeo Saito, Masashi Ikeda, Taisei Mushiroda, et al.
Neuropsychopharmacology Reports|July 1, 2020
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" projectKayo Ichihashi, Hikaru Hori, Naomi Hasegawa, et al.
Pageof 47